SCHEMBL5717014

SCHEMBL5717014

CCC1(C(=O)O)CCCCN1S(=O)(=O)c1ccc(C(F)F)cc1

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.36
ITGA4 P13612 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TRPA1 O75762 2/20 0.34
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717180 0.85 ITGB1 (0.38) ITGB1ITGA4ALDH1A1NPC1MAPT
SCHEMBL5717206 0.84 ALDH1A1 (0.43) ALDH1A1TRPA1
SCHEMBL5717229 0.84 ALDH1A1 (0.43) ALDH1A1TRPA1
SCHEMBL5717084 0.83 ITGB1 (0.39) ITGB1ITGA4ALDH1A1NPC1MAPT
SCHEMBL5717098 0.81 TDP1 (0.39) ITGB1ITGA4ALDH1A1NPC1MAPT
SCHEMBL10890025 0.72 CYP2D6 (0.46) ALDH1A1POLBMAPTSMN1; SMN2MEN1
SCHEMBL16634924 0.72 TRPA1 (0.50) ALDH1A1KDM4EPOLBMAPTSMN1; SMN2
SCHEMBL16634923 0.72 TRPA1 (0.50) ALDH1A1KDM4EPOLBMAPTSMN1; SMN2
SCHEMBL16635481 0.71 TRPA1 (0.53) ALDH1A1KDM4EMAPTSMN1; SMN2TRPA1
SCHEMBL16635482 0.71 TRPA1 (0.53) ALDH1A1KDM4EMAPTSMN1; SMN2TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP disclosed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO disclosed